Table 1.
Direct health care costs associated with health conditions considered in the analysis
| Direct annual costs | Initial value | Actualized cost | Reference |
|---|---|---|---|
| Chronic hepatitis | €246 | €288 | 10,31,32 |
| Compensated cirrhosis | €347 | €407 | 10,31,32 |
| Decompensated cirrhosis | €5,466 | €6,409 | 10,31,32 |
| Carcinoma | €6,075 | €7,124 | 10,31,32 |
| Transplantation (surgery) | €80,199 | €80,199 | 30 |
| Transplantation (1st year treatment) | €4,729 | €4,729 | 10,31,32 |
| Drug costs | Weekly cost | Treatment (number of weeks) | Reference |
|
| |||
| Peginterferone-2a + ribavirin | €283 | 48 | 20 |
| Peginterferone-2b + ribavirin | €261 | 48 | 20 |
| Boceprevir | €643 | 35 | 33,34 |
| Telaprevir | €1,880 | 12 | 33,35 |